MALAT1 and nasopharyngeal carcinoma: MALAT1 is aberrantly expressed in pancreatic cancer, lung cancer, breast cancer, colorectal cancer, gastric cancer, nasopharyngeal carcinoma, hepatocellular carcinoma, and osteosarcoma [62].